If you have diabetes, your doctor might suggest Tresiba (insulin degludec) as a treatment option for you. Tresiba is a prescription medication. It’s used long term to manage blood sugar levels in ...

Tresiba (insulin degludec) is a prescription drug that’s used to manage high blood sugar in people with diabetes. Tresiba’s cost may depend on your dosage, your health insurance, and the pharmacy you ...

Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) adopted positive opinions, recommending marketing authorisations, ...

Bagsværd, Denmark, 29 January 2016 - Novo Nordisk today announced the headline results from SWITCH 2, the first of two 2x32-weeks randomised, double-blind, cross-over, treat-to-target trials, ...

The expanded use for Novo Nordisk's new basal insulin comes 15 months after the initial FDA approval. Novo Nordisk has gained FDA approval for children and adolescents to use Tresiba (insulin degludec ...

Novo Nordisk announced that the Food and Drug Administration (FDA) has approved an expanded use for Tresiba (insulin degludec) injection to improve glycemic control in children and adolescents with ...

Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration (FDA) approved the new drug application for Tresiba ® (insulin degludec injection), a ...

Treatment with Tresiba (insulin degludec injection) resulted in significantly lower rates of overall, nocturnal, and severe hypoglycemia vs. insulin glargine U-100, according to new data from two ...

Novo Nordisk-manufactured human insulin can be purchased at Walmart stores without a prescription for $24.88 a vial (except in Indiana). What's False The most commonly prescribed form of insulin is ...

Tresiba (insulin degludec) may not be safe to use while pregnant or breastfeeding. Factors including the form you take or the condition being treated may determine whether you should use the drug ...

The news keeps getting better for patients with diabetes. Novo Nordisk has announced it is lowering the list prices of several insulin products by up to 75% for people living with type 1 and type 2 ...

New studies on the effectiveness of Novo Nordisk's newest insulin have not been enough to convince Express Scripts to give it preferred status on its formulary. New studies on the effectiveness of ...